Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 560 (ZNF560) is a member of the zinc finger protein family characterized by the presence of C2H2-type zinc finger domains that enable DNA binding and transcriptional regulation. It is predicted to act as a sequence-specific transcription factor and localizes to the nucleus. ZNF560 is associated with transcriptional regulation via RNA polymerase II and is implicated in cancer biology, including osteosarcoma and prostate cancer, with higher expression linked to worse patient outcomes. It has no direct role as a receptor, enzyme, or transporter, and is not currently known to interact with specific drugs.
Not applicable for drugs, but ZNF560 functions by binding DNA and regulating target gene transcription
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 560 (ZNF560).